BCE Emergis Sells U.S. Care Management Operations for US$10 Million.

Business Editors/High-Tech Writers

MONTREAL--(BUSINESS WIRE)--Feb. 26, 2004

BCE Emergis (TSX:IFM) announced today that it had reached an agreement to sell all of the shares of its care management subsidiary National Health Services (NHS), for US$10 million (approximately CA$13.3 million) in cash to SHPS Holdings, Inc. of Louisville, Kentucky. The transaction, expected to close in early March 2004, is subject to customary closing conditions.

"The sale is consistent with the plan we announced earlier this year to sell our U.S. health operations, and to find a strategic buyer that would carry on our care management services. It will improve our ability to focus on areas where we have unique expertise and core competencies in claims, payments, loans processing and related security services," said Tony Gaffney, President and Chief Executive Officer of BCE Emergis.

SHPS Holdings, through its wholly owned subsidiary SHPS, Inc. offers consulting, human resources and benefits outsourcing, and health management services to employers, health plans and government agencies who are seeking to improve their performance and lower the cost of administrative services. SHPS is a Welsh, Carson, Anderson & Stowe (WCAS) company. WCAS is a private equity firm based in New York.

About BCE Emergis

BCE Emergis Inc. is a leading North American eBusiness company. Its core operations consist of supplying eBusiness solutions to the financial services and health industries in North America, automating transactions between companies and allowing them to interact and transact electronically. Its leading technologies are centred on claims, loan-related document processing, payment solutions and related security services.

BCE Emergis customers include leading North American health insurers, top U.S. banks, the top six Canadian banks and a number of North America's largest enterprises. The Company's shares (TSX: IFM) are included in the S&P/TSX Composite Index.

Certain statements made in this press release are forward-looking and are subject to important risks, uncertainties and assumptions. The results or events predicted in these forward-looking statements may differ materially from actual results or events. Other than sale of BCE Emergis' U.S. health operations, these statements do not reflect the potential impact of any non-recurring items or of any dispositions, monetizations, mergers, acquisitions, other business combinations or other transactions that may be announced or that may occur after the date hereof. Other factors that could cause results or events to differ materially from current expectations include, among other things: general and economic factors, adoption of eBusiness, the adoption rate of our solutions by customers, response to industry's rapid pace of change, competition, operating results, success of U.S.-based operations, control by BC, integration of past acquisitions, strategic relationships, dependence on contracting medical service providers, exposure to professional liability, defects in software or failures in the processing of transactions, security and privacy breaches, key personnel, protection of intellectual property, intellectual property infringement claims, integrity of public key cryptography technology, and industry and government regulation. For additional information with respect to certain of these and other factors, refer to BCE Emergis Inc.'s Annual Report (Management's Discussion and Analysis) and the BCE Emergis Inc. Annual Information Form (Risks and Uncertainties) filed with the Canadian securities commissions.

THE FORWARD-LOOKING STATEMENTS CONTAINED IN THIS NEWS RELEASE REPRESENT THE EXPECTATIONS OF BCE EMERGIS INC. AND ITS SUBSIDIARIES AS AT FEBRUARY 26, 2004 AND, ACCORDINGLY, ARE SUBJECT TO CHANGE AFTER SUCH DATE. HOWEVER, BCE EMERGIS INC. AND ITS SUBSIDIARIES DISCLAIM ANY INTENTION OR OBLIGATION TO UPDATE OR REVISE ANY FORWARD-LOOKING STATEMENTS, WHETHER AS A RESULT OF NEW INFORMATION, FUTURE EVENTS OR OTHERWISE